Barclays raised the firm’s price target on Argenx (ARGX) to EUR 880 from EUR 850 and keeps an Overweight rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Immunovant upgraded to Outperform at Wolfe on improving Graves’ perception
- argenx: Leadership Continuity and Pipeline Milestones Underpin Sustained Buy Rating and $1,006 Price Target
- argenx: Leadership Transition, Pipeline Strength, and Commercial Expansion Support Buy Rating and $915 Target
- Argenx Unveils CEO Succession as Co‑Founder Moves to Chair Role
- Argenx CEO Tim Van Hauwermeiren to transition to chair, Karen Massey to succeed